DocDollars

Exeltis, USA Inc.

NJ · United States · Reporting entity ID 100000136420

Total reported 2019–2025
$38.0M
#202 of 2,960 reporting companies — 0% of all reported industry payments
$4.17M in general payments across 95,545 records, plus $33.9M in research funding across 5,157 records.

How it breaks down

General payments $4,171,793
Research funding $33,850,690

Where this comes from

Figures are from the CMS Open Payments “payments grouped by reporting entity” dataset, queried live. Reporting entities are applicable manufacturers and group purchasing organisations required to report under the Sunshine Act.

Summary

Exeltis, USA Inc. reported $38.0M to US doctors and teaching hospitals from 2019 to 2025, ranking #202 of 2,960 reporting companies. 89% of that was research funding and 11% general payments such as consulting, speaking, food and travel. 95,545 general payment records and 5,157 research records were filed.

Common questions about Exeltis, USA Inc.

How much has Exeltis, USA Inc. paid US doctors?

Exeltis, USA Inc. reported $38,022,483 to US physicians and teaching hospitals across the 2019–2025 Open Payments program years: $4,171,793 in general payments, $33,850,690 in research funding.

How does Exeltis, USA Inc. rank among drug and device companies?

It ranks #202 of 2,960 reporting entities by total reported value, about 0% of all industry payments in the dataset.

Does a payment from Exeltis, USA Inc. mean a doctor did something wrong?

No. Open Payments records transfers of value such as speaking fees, consulting, meals, travel and research funding. The data shows the relationship, not its effect on prescribing or care.